[1]
J. . Xu, Y. . Jie, T. . Dong, Q. Li, and X. Liu, “Modulation of Circulating Inflammatory Biomarkers by SGLT2 Inhibitors in Diabetic Patients with Acute Myocardial Infarction: A Quantitative Meta-Analysis of Laboratory Evidence: SGLT2 Inhibitors and Inflammatory Biomarkers in Diabetic AMI”, J Med Biochem, vol. 45, no. 6, pp. 1207–1221, Mar. 2026, doi: 10.5937/jomb0-65034.